Ascletis Pharma Inc.
ASCLF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$88 | -$171 | -$130 | -$128 |
| Dep. & Amort. | $9 | $10 | $10 | $10 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $1 | $2 | -$1 |
| Change in WC | $0 | $16 | $0 | $53 |
| Other Non-Cash | -$98 | $5 | -$85 | -$10 |
| Operating Cash Flow | -$173 | -$138 | -$203 | -$76 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$2 | $0 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $905 | $719 | $262 | $13 |
| Investing Cash Flow | $905 | $717 | $262 | $8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$13 | -$99 | $0 | -$69 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | $40 | -$45 | -$1 |
| Financing Cash Flow | -$14 | -$58 | -$45 | -$70 |
| Forex Effect | -$1 | $0 | $0 | -$1 |
| Net Chg. in Cash | $0 | $0 | $6 | -$70 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $6 | -$70 |
| End Cash | $0 | $0 | $6 | -$70 |
| Free Cash Flow | -$173 | -$140 | -$203 | -$81 |